NALOXONE AND MORTALITY IN THE GERBIL STROKE MODEL

被引:4
作者
BENZEL, EC
MUSGROVE, CC
KESTERSON, L
机构
关键词
D O I
10.1097/00007611-198905000-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:555 / 557
页数:3
相关论文
共 23 条
[1]   A DOSE-ESCALATION STUDY OF LARGE DOSES OF NALOXONE FOR TREATMENT OF PATIENTS WITH ACUTE CEREBRAL-ISCHEMIA [J].
ADAMS, HP ;
OLINGER, CP ;
BARSAN, WG ;
BUTLER, MJ ;
GRAFFRADFORD, NR ;
BROTT, TG ;
BILLER, J ;
DAMASIO, H ;
TOMSICK, T ;
GOLDBERG, M ;
SPILKER, JA ;
BERLINGER, E ;
DAMBROSIA, J ;
BIROS, M ;
HOLLERN, R .
STROKE, 1986, 17 (03) :404-409
[2]   NALOXONE REVERSAL OF ISCHEMIC NEUROLOGIC DEFICITS IN BABOONS IS NOT MEDIATED BY SYSTEMIC EFFECTS [J].
BASKIN, DS ;
KIECK, CF ;
HOSOBUCHI, Y .
LIFE SCIENCES, 1982, 31 (20-2) :2201-2204
[3]  
BASKIN DS, 1981, LANCET, V2, P272
[4]   NALOXONE REVERSAL AND MORPHINE EXACERBATION OF NEUROLOGIC DEFICITS SECONDARY TO FOCAL CEREBRAL-ISCHEMIA IN BABOONS [J].
BASKIN, DS ;
KIECK, CF ;
HOSOBUCHI, Y .
BRAIN RESEARCH, 1984, 290 (02) :289-296
[5]  
BASKIN DS, 1984, J NEUROSURG, V60, P1328
[6]   DIAGNOSIS OF REVERSIBLE VERSUS IRREVERSIBLE CEREBRAL-ISCHEMIA BY THE INTRAVENOUS ADMINISTRATION OF NALOXONE [J].
ESTANOL, B ;
AGUILAR, F ;
CORONA, T .
STROKE, 1985, 16 (06) :1006-1009
[7]   OPIATE ANTAGONISTS IN THE TREATMENT OF STROKE (REPRINTED) [J].
FADEN, AI .
STROKE, 1984, 15 (03) :575-578
[8]   TREATMENT OF EXPERIMENTAL STROKE - COMPARISON OF NALOXONE AND THYROTROPIN RELEASING HORMONE [J].
FADEN, AI ;
HALLENBECK, JM ;
BROWN, CQ .
NEUROLOGY, 1982, 32 (10) :1083-1087
[9]   A DOUBLE-BLIND TRIAL OF NALOXONE IN THE TREATMENT OF ACUTE STROKE [J].
FALLIS, RJ ;
FISHER, M ;
LOBO, RA .
STROKE, 1984, 15 (04) :627-629
[10]   INCREASE OF BETA-ENDORPHIN LEVELS IN CEREBROSPINAL-FLUID BUT NOT IN PLASMA IN PATIENTS WITH CEREBRAL INFARCTION [J].
FURUI, T ;
SATOH, K ;
ASANO, Y ;
SHIMOSAWA, S ;
HASUO, M ;
YAKSH, TL .
JOURNAL OF NEUROSURGERY, 1984, 61 (04) :748-751